AI in clinical trials presents key market opportunities by enhancing patient recruitment, optimizing trial designs, and automating tasks, thus reducing time and costs. Adoption is driven by the need ...

The National Nuclear Security Administration’s deputy administrator for defense programs argued in a memo last month that Los Alamos National Laboratory should increase its annual production of ...

In December, the federal health department asked for feedback on how to boost the use of artificial intelligence for clinical ...